Louis M. Staudt

Also affiliated with National Cancer Institute, Center for Cancer Research

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile

4.0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Uniform genomic data analysis in the NCI Genomic Data Commons

Nature Communications(2021)10.1038/s41467-021-21254-9

Top 6%

3.6DataRank

Top 6%148 citations

Kyle M. Hernandez, Jeremiah Savage, Shenglai Li, Daniel P. Miller, Stuti Agrawal +5 more

Papers

Driven by 47 papers — median percentile 75. Top paper: “Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL”.

Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL

Cancer Cell(2021)10.1016/j.ccell.2021.10.006

N/A

5.4DataRank · unranked

314 citations

George W. Wright, Da Wei Huang, Brendan P. Hodkinson, Sriram Balasubramanian, Yue Fan +4 more

Toward best practice in cancer mutation detection with whole-genome and whole-exome sequencing

Nature Biotechnology(2021)10.1038/s41587-021-00994-5

N/A

3.8DataRank · unranked

215 citations

Luyao Ren, Zhong Chen, Li Tai Fang, Yongmei Zhao, Justin Lack +85 more

Uniform genomic data analysis in the NCI Genomic Data Commons

Nature Communications(2021)10.1038/s41467-021-21254-9

Top 6%

3.6DataRank

Top 6%148 citations

Kyle M. Hernandez, Jeremiah Savage, Shenglai Li, Daniel P. Miller, Stuti Agrawal +5 more

Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma

New England Journal of Medicine(2024)10.1056/nejmoa2401532

N/A

1.5DataRank · unranked

68 citations

Rahul Lakhotia, Stefania Pittaluga, James D. Phelan, Da Wei Huang, George W. Wright +31 more

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

Nature(2000)10.1038/35000501

N/A

1.4DataRank · unranked

9923 citations

Michael B. Eisen, R. Eric Davis, Chi Ma, Izidore S. Lossos, Andreas Rosenwald +32 more

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

Blood(2022)10.1182/blood.2022015851

N/A

1.1DataRank · unranked

1538 citations

Elaine S. Jaffe, James R. Cook, Leticia Quintanilla‐Martínez, Steven H. Swerdlow, Kenneth C. Anderson +68 more

A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications

Cancer Cell(2020)10.1016/j.ccell.2020.03.015

N/A

1.1DataRank · unranked

1106 citations

Da Wei Huang, James D. Phelan, Zana Coulibaly, Sandrine Roulland, Ryan M. Young +13 more

Targeting N-linked Glycosylation for the Therapy of Aggressive Lymphomas

Cancer Discovery(2023)10.1158/2159-8290.cd-22-1401

N/A

0.917DataRank · unranked

28 citations

Jiji Chen, Jiamin Liu, Frank Schnütgen, Julius C. Enßle, Michele Ceribelli +24 more

Molecular Features of Cancers Exhibiting Exceptional Responses to Treatment

Cancer Cell(2020)10.1016/j.ccell.2020.10.015

N/A

0.698DataRank · unranked

104 citations

Naoko Takebe, Toshinori Hinoue, Katherine A. Hoadley, Maria Cardenas, Alina M. Hamilton +41 more

Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma

Blood(2022)10.1182/blood.2022016534

N/A

0.673DataRank · unranked

88 citations

Kostiantyn Dreval, Daniela S. Gerhard, Laura K. Hilton, Jeremy S. Abramson, Richard F. Ambinder +63 more

MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma

Haematologica(2021)10.3324/haematol.2020.271957

N/A

0.663DataRank · unranked

82 citations

Blanca González‐Farré, Alina Nicolae, Svetlana Pack, Guillem Clot, Ferran Nadeu +21 more

TMEM30A loss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphoma

Nature Medicine(2020)10.1038/s41591-020-0757-z

N/A

0.661DataRank · unranked

81 citations

Shannon Healy, Ali Bashashati, Saeed Saberi, Christoffer Hother, Anja Mottok +52 more

Rewiring of B cell receptor signaling by Epstein–Barr virus LMP2A

Proceedings of the National Academy of Sciences(2020)10.1073/pnas.2007946117

N/A

0.644DataRank · unranked

72 citations

Federico Comoglio, Arthur L. Shaffer, Yanlong Ji, Kuan‐Ting Pan, Sebastian Scheich +13 more

BTK drives neutrophil activation for sterilizing antifungal immunity

Journal of Clinical Investigation(2024)10.1172/jci176142

N/A

0.510DataRank · unranked

29 citations

Marissa A. Zarakas, Andrew Wishart, Mark Roschewski, Mariano A. Aufiero, Ágnes Donkó +23 more

Molecular targets of glucocorticoids that elucidate their therapeutic efficacy in aggressive lymphomas

Cancer Cell(2024)10.1016/j.ccell.2024.04.007

N/A

0.505DataRank · unranked

28 citations

Michele Ceribelli, James D. Phelan, Björn Häupl, Da Wei Huang, George W. Wright +19 more

Phase 1b/2 study of ibrutinib and lenalidomide with dose-adjusted EPOCH-R in patients with relapsed/refractory diffuse large B-cell lymphoma*

Leukemia & lymphoma/Leukemia and lymphoma(2021)10.1080/10428194.2021.1907371

N/A

0.494DataRank · unranked

7 citations

Tycel Phillips, Leslie Popplewell, Sven de Vos, Saurabh Chhabra, Amy Kimball +8 more

A Multi-scale, Multiomic Atlas of Human Normal and Follicular Lymphoma Lymph Nodes

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.06.03.494716

Top 44%

0.424DataRank

Top 44%7 citations

Ekaterina Postovalova, Arina Varlamova, Alexander Bagaev, Maria Sorokina, Olga Kudryashova +33 more

The anti‐CD47 antibody magrolimab with obinutuzumab and venetoclax in relapsed or refractory indolent B‐cell lymphomas

British Journal of Haematology(2025)10.1111/bjh.20219

N/A

0.241DataRank · unranked

4 citations

Christopher Melani, Stefania Pittaluga, Max J. Gordon, James D. Phelan, Jagan Muppidi +7 more

An Assessment of Kinase Selectivity, Enzyme Inhibition Kinetics and in Vitro Activity for Several Bruton Tyrosine Kinase (BTK) Inhibitors

ACS Pharmacology & Translational Science(2025)10.1021/acsptsci.5c00412

N/A

0.165DataRank · unranked

2 citations

Xiaohu Zhang, Patricia Alfonso, Patrick J. Morris, Carleen Klumpp‐Thomas, Christopher Melani +12 more

A phase 1 study of interleukin-15 in combination with mogamulizumab in relapsed and refractory T-cell malignancies

Blood Neoplasia(2024)10.1016/j.bneo.2024.100054

N/A

0.165DataRank · unranked

2 citations

Sigrid Dubois, Miloš D. Miljković, Samuel Y. Ng, Bonita R. Bryant, Rahul Lakhotia +8 more

Venetoclax, ibrutinib, prednisone, obinutuzumab, and lenalidomide (ViPOR) in relapsed/refractory (R/R) and treatment‐naïve (TN) mantle cell lymphoma (MCL)

Hematological Oncology(2023)10.1002/hon.3164_437

N/A

0.104DataRank · unranked

1 citations

Rahul Lakhotia, Stefania Pittaluga, J. D. Phelan, Y. Yang, Theresa Davies‐Hill +17 more

Functional genomics identifies N-acetyllactosamine extension of complex N-glycans as a mechanism to evade lysis by natural killer cells

Cell Reports(2024)10.1016/j.celrep.2024.114105

N/A

0DataRank · unranked

18 citations

James S. Woods, Yanlong Ji, Sebastian Scheich, Fei Mo, Sumati Rajagopalan +7 more

Multi-Component, Time-Course screening to develop combination cancer therapies based on synergistic toxicity

Proceedings of the National Academy of Sciences(2024)10.1073/pnas.2413372121

N/A

0DataRank · unranked

8 citations

Frances A. Tosto, Xiaohu Zhang, Christopher Melani, Mark Roschewski, Erin Beck +13 more

A phase 1 study of interleukin-15 in combination with mogamulizumab in relapsed and refractory T-cell malignancies

Maryland Shared Open Access Repository (USMAI Consortium)(2024)10.13016/m2trio-fqf2

N/A

0DataRank · unranked

0 citations

Sigrid Dubois, Miloš Miljkovi?, Samuel Y. Ng, Bonita R Bryant, Rahul Lakhotia +8 more

DNA Methylation Epitypes of Burkitt Lymphoma with Distinct Molecular and Clinical Features

Blood Cancer Discovery(2025)10.1158/2643-3230.bcd-24-0240

N/A

0DataRank · unranked

4 citations

Carlos A. García‐Prieto, Kostiantyn Dreval, Laura K. Hilton, Jeremy S. Abramson, Nancy L. Bartlett +34 more

The FBXO45–GEF-H1 Axis Controls Germinal Center Formation and B-cell Lymphomagenesis

Cancer Discovery(2025)10.1158/2159-8290.cd-24-0442

N/A

0DataRank · unranked

4 citations

Xiaofei Chen, Kaiyu Ma, Rui Wu, Huan-Chang Liang, Richa Kapoor +27 more

Biphasic control of the B cell transcriptome by mTORC1 and GSK3

Cell Reports(2025)10.1016/j.celrep.2025.116361

N/A

0DataRank · unranked

0 citations

Tomoya Kanno, Solji Park, Wendy du Bois, Yongbing Zhao, Paweł Trzaskoma +6 more

Genome-wide Screens Identify Lineage- and Tumor-Specific Genes Modulating MHC-I- and MHC-II-Restricted Immunosurveillance of Human Lymphomas

Immunity(2020)10.1016/j.immuni.2020.11.002

N/A

0DataRank · unranked

143 citations

James D. Phelan, Megan E. Gumina, Boya Wang, Jesse H. Arbuckle, Jaroslav Hollý +14 more

Histone H1 loss drives lymphoma by disrupting 3D chromatin architecture

Nature(2020)10.1038/s41586-020-3017-y

N/A

0DataRank · unranked

267 citations

Andreas Kloetgen, Matt Teater, Adewola Osunsade, Jeannie M. Camarillo, Christopher R. Chin +24 more

Regulation of B cell receptor-dependent NF-κB signaling by the tumor suppressor KLHL14

Proceedings of the National Academy of Sciences(2020)10.1073/pnas.1921187117

N/A

0DataRank · unranked

57 citations

James D. Phelan, George W. Wright, Björn Häupl, Da Wei Huang, Arthur L. Shaffer +7 more

Gene Expression Profiling of Mediastinal Gray Zone Lymphoma and Its Relationship to Primary Mediastinal B-cell Lymphoma and Classical Hodgkin Lymphoma

Blood Cancer Discovery(2020)10.1158/2643-3230.bcd-20-0009

N/A

0DataRank · unranked

48 citations

Alina Nicolae, George W. Wright, Christopher Melani, Mark Roschewski, Seth M. Steinberg +5 more

A Cyclin D1–Dependent Transcriptional Program Predicts Clinical Outcome in Mantle Cell Lymphoma

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2868

N/A

0DataRank · unranked

14 citations

Robert Alberó, Guillem Clot, Giancarlo Castellano, Alba Navarro, Cristina Capdevila +15 more

Genome-wide Screens Identify Lineage- and Tumor Specific-Genes Modulating MHC-I and MHC-II Immunosurveillance in Human Lymphomas

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.03.13.989558

N/A

0DataRank · unranked

2 citations

James D. Phelan, Megan E. Gumina, Boya Wang, Jesse H. Arbuckle, Jaroslav Hollý +14 more

Most non-canonical proteins uniquely populate the proteome or immunopeptidome

Cell Reports(2021)10.1016/j.celrep.2021.108815

N/A

0DataRank · unranked

209 citations

Marie‐Pierre Hardy, Jaroslav Hollý, Éric Bonneil, Chantal Durette, Mathieu Courcelles +8 more

The next horizon in precision oncology: Proteogenomics to inform cancer diagnosis and treatment

Cell(2021)10.1016/j.cell.2021.02.055

N/A

0DataRank · unranked

188 citations

Jean C. Zenklusen, Louis M. Staudt, James H. Doroshow, Douglas R. Lowy, Henry Rodriguez

Overcoming Acquired Epigenetic Resistance to BTK Inhibitors

Blood Cancer Discovery(2021)10.1158/2643-3230.bcd-21-0063

N/A

0DataRank · unranked

61 citations

James D. Phelan, James Q. Wang, Dawei Huang, George W. Wright, Monica Kasbekar +26 more

Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in adult T-cell leukemia/lymphoma

Blood(2021)10.1182/blood.2021012734

N/A

0DataRank · unranked

41 citations

Sarvesh Kumar, Joji Shimono, Anusara Daenthanasanmak, Sigrid Dubois, Yuquan Lin +22 more

Insertion of atypical glycans into the tumor antigen-binding site identifies DLBCLs with distinct origin and behavior

Blood(2021)10.1182/blood.2021012052

N/A

0DataRank · unranked

34 citations

Joel D. Allen, Dean Bryant, Philip Rock, Enrica Antonia Martino, Beatriz Valle‐Argos +17 more

Comparison of immunohistochemistry and gene expression profiling subtyping for diffuse large B‐cell lymphoma in the phase III clinical trial of R‐CHOP ± ibrutinib

British Journal of Haematology(2021)10.1111/bjh.17450

N/A

0DataRank · unranked

12 citations

Songbai Wang, Christopher Major, Brendan P. Hodkinson, Michael Schäffer, Laurie H. Sehn +10 more

Non-coding NFKBIZ 3′ UTR mutations promote cell growth and resistance to targeted therapeutics in diffuse large B-cell lymphoma

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.05.22.445261

N/A

0DataRank · unranked

3 citations

Jie Gao, Shannon Healy, Christopher Rushton, Nicole Thomas, Laura K. Hilton +14 more

In vivo CRISPR screens reveal a HIF-1α-mTOR-network regulates T follicular helper versus Th1 cells

Nature Communications(2022)10.1038/s41467-022-28378-6

N/A

0DataRank · unranked

45 citations

James D. Phelan, Silvia Preite, Julio Gómez‐Rodríguez, K. Johansen, Hirofumi Shibata +11 more

TLR9 ligand sequestration by chemokine CXCL4 negatively affects central B cell tolerance

The Journal of Experimental Medicine(2023)10.1084/jem.20230944

N/A

0DataRank · unranked

16 citations

Marie Dominique Ah Kioon, Yolanda García-Carmona, Salomé Glauzy, David J. Oliver, Natsuko Yamakawa +23 more

Analysis and therapeutic targeting of the IL-1R pathway in anaplastic large cell lymphoma

Blood(2023)10.1182/blood.2022019166

N/A

0DataRank · unranked

6 citations

Wenjun Wu, Wei Wei, Wenming Xiao, Michelle Lei, Kathy Q. Cai +10 more

Data from A Cyclin D1–Dependent Transcriptional Program Predicts Clinical Outcome in Mantle Cell Lymphoma

(2023)10.1158/1078-0432.c.6530333

N/A

0DataRank · unranked

0 citations

Robert Alberó, Guillem Clot, Giancarlo Castellano, Alba Navarro, Cristina Capdevila +15 more

Multi-omic profiling of follicular lymphoma reveals changes in tissue architecture and enhanced stromal remodeling in high-risk patients

Cancer Cell(2024)10.1016/j.ccell.2024.02.001

N/A

0DataRank · unranked

64 citations

Ekaterina Postovalova, Arina Varlamova, Alexander Bagaev, Maria Sorokina, Olga Kudryashova +36 more

Response to Bruton’s tyrosine kinase inhibitors in aggressive lymphomas linked to chronic selective autophagy

Cancer Cell(2024)10.1016/j.ccell.2023.12.019

N/A

0DataRank · unranked

28 citations

Sebastian Scheich, Jaewoo Choi, George W. Wright, Björn Häupl, Ryan M. Young +28 more

Molecular Determinants of Sensitivity to Polatuzumab Vedotin in Diffuse Large B-Cell Lymphoma

Cancer Discovery(2024)10.1158/2159-8290.cd-23-0802

N/A

0DataRank · unranked

27 citations

James D. Phelan, Jaewoo Choi, Galina Shevchenko, Rachel E. Fenner, Xin Yu +16 more

Louis M. Staudt

Indexed papers

Top data-sharing exemplar

Papers